Dr. Manish Nivsarkar

Total Experience 23 years

Educational Qualification : M.Sc., Ph.D.

Research Area : Molecular Pharmacology, Pre-clinical and Clinical Pharmacokinetics of Synthetic and Herbal Drugs, Development of Bioenhancement Techniques, Novel Drug Delivery System, Targeted Gene Delivery, Cancer, Diabetes and Toxicoproteomics, Reproductive Physiology, Natural Products

General information
Designation Director
Office Phone 07927439375
Email director@perdcentre.com , manishn@perdcentre.com

Brief about you

Dr. Manish Nivsarkar has 23 years of research and 8 years of teaching experience. He stared his carrier as a Research Scientist in Sir H.N.M.R.S Mumbai, where he served from 1993-1996, then he joined B. V. Patel PERD Centre as Scientist A, currently he is director of B. V. Patel PERD Centre. He completed his PhD from Devi Ahilya Vishwavidyalaya Indore. Dr. Manish has actively participated and organized various national and international symposia and conferences. He is recipient of Indian Drugs Best Paper Award (2002) for the best paper in the discipline of Pharmacology and Best Poster Award in 14th National Convention of Indian Society of Pharmacognosy, 2010. He has more than 122 research publications and general articles in many national and international peer-reviewed journals to his credit. He is a recognized guide from Nirma University (Ahmedabad), Sardar Patel University (Vallah Vidyanagar), Bhavnagar University and Ahmedabad University.

His area of expertise includes Reproductive Physiology, Pre-clinical and Clinical Pharmacokinetics of Synthetic and Herbal Drugs, Development of Bioenhancement Techniques, Novel Drug Delivery System, Targeted Gene Delivery, Cancer, Diabetes and Toxicoproteomics. He has commendable expertise in development of toxicity studies, development and validation of animal models for pharmacology, setting up of toxicokinetics system.

Current Activities :

Experience
Research 23 years
Teaching 8 years
Industry -
Contact
Website www.perdcentre.com
Membership IPS, LASA, SSE
Specialization
Specialization Areas: Pre-Clinical and clinical studies, Pharmacology, Toxicology, Targeted delivery, Cancer therapeutics, CVS, Diabetes, Contraception, animal micro surgery
Subject Taught UG: -
Subject Taught PG: -
Institute / Organization Designation Duration
B. V. Patel PERD Centre Director March 2012 till date
B. V. Patel PERD Centre Joint Director, Head Department of Pharmacology and Toxicology December 2009 to February 2012
B. V. Patel PERD Centre Assistant Director, Head Department of Pharmacology and Toxicology August 2005 to November 2009
B. V. Patel PERD Centre Scientist-C, Head Department of Pharmacology and Toxicology June 2003 to July 2005
B. V. Patel PERD Centre Scientist-B, Head Department of Pharmacology and Toxicology December 1998 to May 2003
B. V. Patel PERD Centre Scientist A, Department of Pharmacology and Toxicology August 1996 to November 1998
Sir. H.N. Medical Research Society, Mumbai Research Scientist October 1993 to August 1996
Devi Ahilya Vishwavidyalaya, Indore Research Associate June 1993 to October 1993

A. International Journal :

Sr. No. Title ISSN / ISBN No Journal / Publisher Volume Year
1 Clinical importance of nonsteroidal anti-inflammatory drug enteropathy: the relevance of tumor necrosis factor as a promising target. 1931-5244 Translational Research In Press 2016
2 CD90 a potential cancer stem cell marker and a therapeutic target. 1574-0153 Cancer Biomarkers/IOS Press In Press 2016
3 Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats. 0378-8741 Journal of Ethnopharmacology/Elsevier Science BV 181, 20-25 2016
4 A novel model for NSAID induced gastroenteropathy in rats 1056-8719 Journal of Pharmacological and Toxicological Methods/ Elsevier Science BV 78, 66-75 2016
5 Role of cortisol and Superoxide dismutase in psychological stress induced anovulation 0016-6480 General and Comparative Endocrinology/ Elsevier Science BV 225, 117-124. 2016
6 Anti-inflammatory, Anti-estrogenic and Anti-implantation Activity of Bergia suffruticosa (Delile) Fenzl. 0973-1296 Pharmacognosy Magazine/Pharmacog Net 11(44, Sup. 3), S407-S413. 2015
7 Abortifacient Potential of Methanolic Extract of Anthocephalus CadambaStem Bark in Mice 0378-8741 Journal of Ethnopharmacology/ Elsevier Science BV 173, 313-317 2015
8 Intestinal P-Glycoprotein: Pharmacokinetic Implications and Approaches for Enhancement of Oral Bioavailability of its Substrates . Journal of Pharmaceutics and Therapeutics/Gratis 1(1) 19-42. 2015
9 Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non Aqueous Solution: A Comparative Bioavailability Study. 0973-709X Journal of Clinical and Diagnostic Research Vol. 9(12), 11-13. 2015
10 Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies. 0014-2999 European Journal of Pharmacology/ Elsevier Science BV 767, 67-76 . 2015
11 Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes 0960-894X Bioorganic And Medicinal Chemistry Letters / Pergamon-Elsevier Science Ltd 25(20), 4428-4433 2015
12 Development of self-emulsifying drug delivery system of itraconazole for oral delivery: formulation and pharmacokinetic consideration 2093-5552 Journal of Pharmaceutical Investigation / Springer Netherlands 45(3), 271-283 2015
13 Solid Lipid Nanoparticles (SLN) of Efavirenz as lymph targeting delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach 0378-5173 International Journal Of Pharmaceutics / Elsevier Science BV 495(1), 439-446 2015
14 Synthesis and Blastocyst Implantation Inhibition potential of Lupeol Derivatives in Female Mice. 1307-6167 Reports On Natural Products / Academy Of Chemistry Of Globe 9(4) 561-566 2015
15 Role of lipid based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulation 1071-7544 Drug Delivery / Taylor & Francis Ltd 22(4), 531-540 2015
16 Multiple Marker-Based Evaluation of Kalanchoe pinnata, Bombax ceiba, and Morus alba Leaves: Quantification of a-Amyrin, Lupeol, and ß-Sitosterol Using High-Performance Thin-Layer Chromatography 0933-4173 Journal Of Planar Chromatography / Akademiai Kiado RT 27(6), 438–443 2014
17 Anti-estrogenic and anti-inflammatory potential of n-hexane fraction of Vitex negundo Linn leaf extract-A probalble mechanism for blastocyst implantation failure in Mus musculus. International Scholarly Research Notices / Hindawi Publishing Corporation Article ID 241946, 1-8 2014
18 An improved and versatile immunosuppression protocol for the development of tumor xenograft in mice 0250-7005 Anticancer Research / International Institute of Cancer research 34(12), 7177-7183 2014
19 The Comparison of Conventional and Novel Fixed Dose Combination of Rifampicin and Isoniazid to Improve Bioavailability of Rifampicin for Treatment of Tuberculosis 2161-1068 Journal Of Mycobacterial Diseases / Omics Online 4, 157. 2014
20 Design and In vivo Evaluation of Gastrointestinal Mucoadhesive Patch System (GMPS) Loaded with Chitosan Nanoparticles 2248-910x (eISSN) International Journal Of Pharmaceutical Development And Technology 4(4), 258-266. 2014
21 Simultaneous quantification of epigallocatechin-3-gallate and Atorvastatin by using HPLC-UV method and its application to pharmacokinetic studies in rats 2249-7781 International Journal Of Pharmaceutical Research And Analysis / Pharma Intelligence 4(5), 292-298 2014
22 Evaluation of GABAergic transmission modulation as a novel functional target for management of multiple sclerosis: Exploring inhibitory effect of GABA on glutamate mediated excitotoxicity Advances in Pharmacological Sciences/ Hindawi Publishing Corporation Article ID632376, 1-6 2014
23 Discovery and pharmacological evaluation of novel thiazolo-thiophene derivative, MCD-KV-10 as an A2A and A2B receptor ligand for management of asthma 1475-6366 Journal of Enzyme Inhibition And Medicinal Chemistry / Taylor & Francis Ltd 30(2), 229-239 2014
24 Development and evaluation of in situ gelling mucoadhesivemicroemulsion of nimodipine for intranasal delivery: an approach for brain targeting 2211-3835 Acta Pharmaceutica Sinica B / Elesevier 4(2), 151-160 2014
25 Simultaneous quantification of rosuvastatin and fenofibric acid by HPLC-UV in rat plasma and its application to pharmacokinetic study 1082-6076 Journal Of Liquid Chromatography And Related Technologies / Taylor & Francis Ltd 37(12), 1673-1684 2014
26 Simultaneous Quantification of Glibenclamide, Simvastatin and Quercetin by using LC-UV method and its application to Pharmacokinetic study in Rats. Chromatography Research International / Hindawi Publishing Corporation Article ID 768160, 1-6 2013
27 Anti-inflammatory activity of the leaves of Bergia suffruticosa investigated on acute and chronic inflammation models in rats 2200-3886 Australian Journal Of Herbal Medicine / National Herbalists Association Of Australia 25 (4), 195-200 2013
28 Implication of novel bis-imidazopyridines for management of Alzheimer’s disease and establishment of its role on protein phosphatase 2A activity in brain 0022-3573 Journal Of Pharmacy And Pharmacology / Wiley-Blackwell 65 (12), 1785-1795 2013
29 Ulcer protective effect of hydroalcholic extract of Bergia suffruticosa in rats 2200-3886 Australian Journal Of Herbal Medicine / National Herbalists Association Of Australia 25(2) 74-78 2013
30 Simultaneous Quantification of Aliskiren, Valsartan and Sitagliptin by using Fluorescence LC Method: Evidence of Pharmacokinetic Interaction in Rats 0009-5893 Chromatographia / Springer Heidelberg 76 (9-10), 515-521 2013
31 Comparative pharmacokinetic profiles of picroside I and II from kutkin, Picrorhiza kurroa extract and its formulation in rat 0357-325X Fitoterapia / Elsevier Science BV 85, 76-83 2013
32 Isolation and TLC-densitometric quantification of Lysergol from the seeds of Ipomoea muricata (Linn.) Jacq. ISRN Chromatography / Hindawi Publishing Corporation Article ID: 134586, 1-6 2013
33 A combination approach for rapid and high yielding purification of bacterial minicells 0167-7012 Journal of Microbiological Methods / Elsevier Science BV 92(3), 340-343 2013
34 Pharmacokinetic study of Berberine from Rasont and implication of lysergol for its bioavailability enhancement 1082-6076 Journal of Liquid Chromatography And Related Technologies / Taylor & Francis Ltd 36(3), 336-348 2013
35 The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound rhein exhibits anti-allergic activity via mast cell stabilization and lipoxygenase inhibition 0378-8741 Journal of Ethnopharmacology / Elsevier Ireland Ltd 141 (1), 469-473 2012
36 Bioequivalence Study of two oral formulations of Metamizole 500 mg in healthy volunteers 0975-8232 International Journal of Pharmaceutical Sciences And Research / Society of Pharmaceutical Sciences And Research 3(6), 1749-1752 2012
37 Antihypertensive efficacy of Lippia nodiflora – whole plant on uninephrotectomized DOCA – salt hypertensive rats 2250-3013 IOSR Journal of Pharmacy 2(6), 24-28 2012
38 Simultaneous quantification of berberine and lysergol by HPLC-UV: Evidence that lysergol enhances the oral bioavailability of berberine in rats 0269-3879 Biomedical Chromatography / Wiley-Blackwell 26(10), 1170–1175 2012
39 TLC-Densitometric Quantification of Negundoside, Ursolic Acid, Eugenol, Lupeol and ß-sitosterol using HPTLC from Vitexnegundo Leaves. 1082-6076 Journal of Liquid Chromatography And Related Technologies / Taylor & Francis Ltd 35 (11), 1565-1584 2012
40 Gastroretentive delivery of rifampicin: in vitro mucoadhesion and in vivo gamma scintigraphy. 0378-5173 International Journal of Pharmaceutics / Elsevier Science BV 411(1-2), 106-112 2011
41 Push-Pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization. 1083-7450 Pharmaceutical Development and Technology / Taylor &Francis Ltd 17 (3), 375-382 2011
42 Detoxification of Nerium indicum roots based on Indian System of Medicine: Phytochemical and Toxicological Evaluation 2353-5288 Acta Poloniae Pharmaceutica - Drug Research /Polish Pharmaceutical Society 68(6), 905-911 2011
43 Hormonal Crosstalk with calcium channel blocker during implantation 1939-6368 Systems Biology in Reproductive Medicine / Taylor & Francis Ltd 57(4), 186-189 2011
44 Exploring the potential of polacrilin potassium as a novel super distintegrant in microcrystalline cellulose based pellets prepared by extrusion-spheronization. 2394-2002 Chronicles of Young Scientists / Medknow Publications & Media Pvt Ltd 2(2), 114-116 2011
45 A novel lipid based oral drug delivery system of Nevirapine. 0975-3818 International Journal of Pharmaceutical Technology and Research 3(2), 1159-1168 2011
46 Investigation of microemulsion system for transdermal delivery of itraconazole. 0976-2094 Journal of Advanced Pharmaceutical Technology And Research / Wolters Kluwer Medknow Publications & Media Pvt Ltd 2(1), 30-38 2011
47 Comparative Bioavailability Study of a New Formulation of Injection of 75 Mg Diclofenac Sodium in 1 Ml with the Conventional Injection of 75 Mg Diclofenac Sodium Given in 3 Ml Volume. 2212-3938 Current Clinical Pharmacology / Bentham Science 6(1), 26-29 2011
48 Formulation and pharmacokinetic evaluation of hard gelatin capsule encapsulating lyophilized Vasa Swaras for improved stability and oral bioavailability of vasicine 0357-325X Fitoterapia / Elsevier Science BV 82(3), 446-453 2011
49 Pharmacokinetic profile of a new formulation of injection diclofenac in Indian volunteers with BMI > 25 1178-7090 Journal of Pain Research / Dove Press 3, 235-240 2010
50 Bioequivalence and pharmackokinetic evaluation of two formulations of paracetamol ER 650 mg: A single dose randomized two period crossover comparison in healthy Indian adult volunteers 0975-7066 International Journal of Current Pharmaceutical Research 2(4) 28-31 2010
51 Comparative pharmacokinetics profile of Vasa Swaras with vasicine and vasicinone 0009-5893 Chromatographia / Springer Heidelberg 71(7), 609-615 2010
52 Multivariate optimization of formulation and process variables influencing physico-mechanical characteristics of site-specific release isoniazid pellets. 0378-5173 International Journal of Pharmaceutics / Elsevier Science BV 388(1-2), 64-72 2010
53 Inhibitory Effect of n-butanol fraction of Moringa oleifera Lam. Seeds on OVA-Induced Airway Inflammation in murine model of asthma 1091-5818 International Journal Of Toxicology / SAGE Publications Inc 28(6), 519-527 2009
54 HPTLC densitometric quantification of Glycyrrhizin, Glycyrrhetinic Acid, Apigenin, Kaempferol and quercetin from Glycyrrhizaglabra. 0009-5893 Chromatographia / Springer Heidelberg 70, 1665-1672 2009
55 Establishing the probable mechanism of L-DOPA in Alzheimer’s disease management 1898-794X Acta Polonica / Polish Academy of Sciences 66(5), 483-486 2009
56 Role of calcium channel in blastocyst implantation: A novel contraceptive target 0792-6855 Journal of Basic and Clinical Physiology and Pharmacology / Walter De Gruyter 20 (1) 43-53 2009
57 Pharmacokinetic profile of a new formulation of injection diclofenac designed for intradeltoid use. 1465-6566 Expert Opinion on Pharmacotherapy / Taylor & Francis Ltd 10(4) 517-522 2009
58 Cyclooxygenase inhibitors: A novel direction for Alzheimer’s management. 1734-1140 Pharmacological Reports / Polish Academy of Sciences 60, 692-698 2008
59 Combination Therapeutic Approach for Asthma and Allergic Rhinitis 2212-3938 Current Clinical Pharmacology / Bentham Science 3(3), 185-197 2008
60 Dissolution test for site-specific release isoniazid pellets in USP Apparatus 3 (reciprocating cylinder): optimization using response surface methodologies. 0939-6411 European Journal Pharmaceutics and Biopharmaceutics / Elsevier Science BV 69(2), 769-775 2008
61 Single and multiple dose toxicokinetics of rofecoxib in Sprague Dawley rats: Implication of drug accumulation and sex differences 0973-2381 Advances in Pharmacology And Toxicology 9 (1) 1-7 2008
62 Serial and Sparse Sampling Approaches in Single and Multiple Dose Toxicokinetic Studies: A comparison. 0975-6299 International Journal of Pharmacology and Biological Sciences 2(1) 71-78 2008
63 2 Amino-5-thazzolyl Motif: A novel scaffold for designing anti-inflammatory agents of diverse structures 0223-5234 European Journal of Medicinal Chemistry / Elsevier France 43 (1), 129-134 2008
64 Endometrial membrane response in Mus musculus during implantation by Vitex negundo Linn. 1806-9614 Animal Reproduction / Brazilian College of Animal Reproduction 4, 46-50 2007
65 Alterations in uterine Environment by Adrenal Feedback Mechanism during Estrous Cycle 2241-5793 Journal of Biological Research / Biomedcentral 8, 217-222 2007
66 Adrenalectomy potentiates the anti-inflammatory activity of a calcium channel blocker 0792-6855 Journal of Basic and Clinical Physiology and Pharmacology / Walter De Gruyter 18(4), 299-306 2007
67 Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study. 1570-0232 Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences / Elsevier Science BV 857(2):219-23 2007
68 A new high performance liquid chromatographic method for determination of atomoxetine in human plasma and its application for pharmacokinetic study 1570-0232 Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences / Elsevier Science BV 850, 356-360 2007
69 Anti-hyperlipidemic effect of Carica papaya L in Sprague-Dawley rats 1118-6267 Nigerian Journal of Natural Products and Medicine / AJOL 10, 69-72 2006
70 Anti-Ulcer activity of Adhatoda vasica Nees 1522-8940 Journal of Herbal Pharmacotherapy / Taylor & Francis 6(2) 43-50 2006
71 Reduction in aluminum induced oxidative stress by meloxicam in rat brain: an in vivo and in vitro study 1028-852X Iranian Biomedical Journal / Pasteur Inst Iran 10(3) 151-155 2006
72 Wound Healing Activity of Hemolok (Sepgard) Gel in Sprague Dawley Rats. 0973-2381 Advances in Pharmacology and Toxicology 7(1), 21-23 2006
73 Wound Healing Activity Of Tridax Procumbens 0973-2381 Advances in Pharmacology and Toxicology 6(1), 1-8 2005
74 Comparative bioavailability of micronized fenofibrate capsule with the newly developed formulation of fenofibrate (FENO-TG) in healthy human volunteers. Cardiology Update (1) 29-32 2005
75 Blastocyst Implantation failure in mice due to “non receptive endometrium”: endometrial alterations by Hibiscus rosasinnensis leaf extract 0010-7824 Contraception / Elsevier Science Inc 71(3), 227-230 2005
76 Determination of oral meloxicam pharmacokinetic parameters in Asian Indians: comparison with German population. 1319-0164 Saudi Arabian Journal of Pharmaceutical Sciences 12(4) 144-149 2004
77 Acute toxicity testing of polymeric binder for use in extended release tablets 2042-7158 Journal of Pharmacy and Pharmacology / Wlley Blackwell 56, 170-172 2004
78 Olanzepine induced thrombocythemia in Spargue-Daley rats 1525-6014  Drug Chemical and Toxicology / Taylor & Francis 27(4) 379-387 2004
79 Novel designing approach for dual inhibitors as anti-inflammatory agents: implication of pyridine template 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 301(1), 183-186 2003
80 Organelle specific enzyme markers as indicators of methylmercury neurotoxicity and antidotal efficacy in mice 0966-0844 Biometals / Springer 16, 279-284 2003
81 Sperm membrane modulation by Sapindus mukorossi during sperm maturation. 1008-582X Asian Journal of Andrology / Medknow Publications & Media Pvt Ltd 4(3), 233-235 2002
82 Involvement of endometrial membrane sulphydryl groups in blastocyst implantation: sulphydryl groups as a potential target for contraceptive research 0010-7824 Contraception / Elsevier Science Inc 64(4) 255-259 2001
83 Sub-acute toxicity of meloxicam a selective COX-2 inhibitor in mice 0973-2381 Advances in Pharmacology and Toxicology 2(2), 27-31 2001
84 Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs is rheumatoid arthritis 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 270, 714-716 2000
85 A regulatory role of sulphydryl groups in modulation of sperm membrane conformation by heavy metals: sulphydryl groups as markers for infertility assessment 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 247, 716-718 1998
86 Modulation of sperm membrane confirmation by pentoxifylline in oligopsermia: a biophysical investigation of sperm membrane in vitro. 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 225, 791-795 1996
87 Free radical induced biophysical modification of membrane lipids: a novel mechanism proposed for the haemorheological alteration by 4,5,8’trimethylpsoralen. Biochemistry and Molecular Biology International 38, 325-333 1996
88 Metal binding and resultant loss of phototoxicity of alfa-terthienyl: metal detoxification versus alpha-terthienyl inactivation. 1432-0800 Bulletin of Environmental Contamination and Toxicology / Springer 15, 183-189 1996
89 Photophysical alterations of erythrocyte membrane by 4, 5, 8’ trimethylpsoralen: membrane response towards psoralen phototherapy. 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 199, 1413-1421 1994
90 Effect of ultraviolet light activated alpha-terthienyl upon anal gills of mosquito larvae: a spin label study. 0305-1978 Biochemical Systematics and Ecology / Pergamon-Elsevier Science Ltd 21, 441-447 1993
91 Generation of superoxide anion radical by alpha-terthienyl in the anal gills of mosquito larvae of aedesaegypti: a new aspect in alpha-terthienyl phototoxicity 0739-4462 Archives of Insect Biochemistry And Physiology / Wiley-Blackwell 19, 261-270 1992
92 Superoxide dismutase inactivation by alpha-terthienyl: a novel observation in thiophene photochemistry 0048-3575 Pesticide Biochemistry and Physiology / Academic Press Inc Elsevier Science 41, 53-59 1991
93 Superoxide dismutase in the anal gills of mosquito larvae of Aedes aegypti: its inhibition by alpha-terthienyl 0739-4462 Archives of Insect Biochemistry and Physiology / Wiley-Blackwell 16(4), 249-255 1991
94 Enhanced axial symmetry at the Fe (II) heme center of peroxidase by ascorbate: the basis for ascorbate dependent peroxidase action 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 180, 597-601 1991
95 Superoxide dismutase activity regulation by spermine: a new dimension in spermine biochemistry and sperm development 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 177, 420-426 1991
96 Superoxide dismutase activation in thyroid and suppression in adrenal: novel pituitary regulatory routes 0014-5793 FEBSLetters / Elsevier Éclence 282, 310-312 1991
97 Superoxide dismutase as a regulatory switch in mammalian testicular steroidogenesis 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 173, 302-308 1990
98 Superoxide anion radical induces lipid phase transitions that mimics temperature induced phase transition phenomenon of membrane lipids 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 172, 601-607 1990
99 Discovery of a novel and alternate hydrogen peroxide generation machinery in the mammalian thyroid gland that modulates iodization of tyrosine. 0006-291X Biochemical and Biophysical Research Communications / Academic Press Inc Elsevier Science 169, 1-7 1990
100 Localization of superoxide dismutase in the ovary and uterus of mice during pregnancy with special reference to luteal steroidogenesis and implantation. 0044-5991 Acta Histochemica et Cytochemica / Japan Society Histochemistry & Cytochemistry 23, 271-279 1990

B. National Journal :

Sr. No. Title ISSN/ISBN No Journal / Publisher Volume Year
1 In vivo evaluation of self-emulsifying drug delivery system for oral delivery of nevirapine 0250-474X Indian Journal of Pharmaceutical Sciences/Medknow Publications & Media Pvt Ltd 76 (3), 218-224 2014
2 Bioequivalence and pharmacokinetic evaluation of two formulations of fenofibrate 145 mg in healthy Indian subjects 2279-0594 Journal of Pharmaceutical and Biomedical Research /Tyagi Pharmacy Association 7(7) 1-5 2011
3 Phytochemical evaluation and radical scavenging activity of three members from family asteraceae 0019-462X Indian Drugs / Indian Drug Manufacturers Association 44(10), 751-756 2007
4 Analgesic and anti-inflammatory activity of hydroalcoholic extract of Morus alba Linn 0019-462X Indian Drugs /Indian Drug Manufacturers Association 44(5), 364-367 2007
5 A New Liquid-Liquid Extraction Method for Determination of Montelukast in Small Volume Human Plasma Samples Using HPLC with Fluorescence Detector 0250-474X Indian Journal of Pharmaceutical Sciences/Medknow Publications & Media Pvt Ltd 68(4) 517-520 2006
6 Zafirlukast pharmacokinetics in healthy Indian male subjects: possibility of interethenic variability The Indian Journal of Allergy, Asthma and Immunology 19(2), 69-73 2005
7 Anti Ulcer Activity of Methanolic Extract of SapindusMukorossi 0019-462X Indian Drugs / Indian Drug Manufacturers Association 42(6), 380-383 2005
8 Bioequivalence of fenofibrate tablet formulations in healthy Indian male subjects 0250-474X Indian Journal of Pharmaceutical Sciences/Medknow Publications & Media Pvt Ltd 67(3), 297-301 2005
9 Anti-Ulcer Activity of Methanolic Extract of Eclipta Alba 0250-474X Indian Journal of Pharmaceutical Sciences/Medknow Publications & Media Pvt Ltd 67(2), 169-172 2005
10 Altered glucose tolerance by guanidinothiourea compound in Sprague-Daley rats: possible mechanism(s) for hyperglycemia 0019-462X Indian Drugs / Indian Drug Manufacturers Association 41(5) 294-297 2004
11 A rapid selective and sensitive method for extraction and analysis of celecoxib in Human Plasma 0019-462X Indian Drugs / Indian Drug Manufacturers Association 41(4) 221-225 2004
12 Modulation of platelet membrane by free radical induced lipid peroxidation. 0019-462X Indian Drugs / Indian Drug Manufacturers Association 40(8), 479-481 2003
13 Pharmacokinetics of olanzepine in Asian Indians and comparison with other population: possibility of inter-ethnic differences. 0019-462X Indian Drugs / Indian Drug Manufacturers Association 39(11) 583-588 2002
14 Launaeanudicaulis leaf juice exhibits anti-inflammatory action in acute and chronic inflammation models in rats. 0019-462X Indian Drugs / Indian Drug Manufacturers Association 39(5), 290-292 2002
15 Alpha-terthienyl: a plant derived new generation insecticide 0011-3891 Current Science/INDIAN ACAD SCIENCES 81(6), 667-672 2001
16 Sub-acute toxicity study of meloxicam a selective COX-2 inhibitor in rats Indian Journal of Toxicology 8(2), 163-168 2001
17 Identification of alpha-terthienyl radical in vitro: a new aspect in alpha-terthienyl phototoxicity 0011-3891 Current Science/ INDIAN ACAD SCIENCES 76(10), 1391-1393 1999

C. Book Chapters :

Sr. No. Title
1 Future Prospects for CRO: Indian Capabilities. Pharma Buzz 6(9) 34-37
2 Pharma Industry – Opportunities Post 2005. Proceedings of Seminar on Chemicals & Pharmaceuticals., Global Investors’ Summit 2005
3 Pulse of Indian Pharma Sector: Issues and opportunities. In: Indian Pharma Industry Issues and Options. PP: 37-54

D. General Articles :

Sr. No. Title
1 Current Perspectives in Bioavailability Enhancement Souvenir, 6th International Symposium on Pharmaceutical Innovation in Science and Technology, Nov. 26-28th, 2010, Ahmedabad, India
2 Applications of Bioinformatics Souvenir, 6th International Symposium on Pharmaceutical Innovation in Science and Technology, Nov. 26-28th, 2010, Ahmedabad, India
3 Search for new contraceptive targets 1st Indo-Japanese International Conference on Advances in Pharmaceutical Research and Technology, Nov. 25-29, 2005, Mumbai, India
Qualification Specialization University Passing Year
Ph.D. Life Science Devi Ahilya Vishwavidyalaya, Indore, M.P. India 1992
M.Sc. Animal Science Rohilkhand University, Bareilly, U.P. India 1987
B.Sc. Zoology, Botany, Chemistry Rohilkhand University, Bareilly, U.P. India 1985
Activity Number
Workshop 17
National Symposium 1
International symposium Scientific member 6
Invited Lectures More than 20

A. Government Projects

Sr. No. Fund Type Agency Start Date Duration
1.      Government of Gujarat Gujarat Council on Science and Technology(GUJCOST) 2016 2 years
2.      Government of India Department of Biotechnology (DBT) 2011 2 years
3.      Government of Gujarat Gujarat State Biotechnology Mission (GSBTM) 2011 2 years
4.      Government of India Department of Biotechnology (DBT) 2009 3 years
5.      Government of India Department of Biotechnology (DBT) 2007 3 years
6.      Government of India Indian Council of Medical Research (ICMR) 2006 2 years
7.      Government of India Department of Biotechnology (DBT) 2004 3 years
8.      Government of India Indian council of Medical Research (ICMR) 2004 2 years
9.      Government of Gujarat Gujarat Council on Science and Technology (GUJCOST) 2004 1 year
10.   Government of Gujarat Gujarat Council on Science and Technology(GUJCOST) 2002 1 year
11.   Government of Gujarat Gujarat Council on Science and Technology (GUJCOST) 2002 2 years
12.   Government of Gujarat Gujarat Council on Science and Technology (GUJCOST) 2002 2 years

B. Industrial Projects

S. No. Study Number
1 Toxicity studies >140
2 Bioequivalence and Bioavailability >100
3 Pharmacological Evaluation studies >70

C. Awards and Patents

Awards
1.      Best Poster Presentation in “international conference on reproductive health with emphasis on occupational, environmental and lifestyle factors” & 26th annual meeting of the Indian society for the study of reproduction and fertility. NIOH Ahmedabad, 2016.
2.      Gandhian Young Technological Innovation Award in field of Pharmacy, 2015
3.      Gufic Prize in47th Annual Conference of the Indian Pharmacological Society (IPSCON) 2014, December 28–30, 2014 at GMCH & NIPER Guwahati, India
4.      4th Prize in International Conference on Diabetes and its Complications, CHARUSAT, Changa, January, 2013
5.      Certificate of Merit - “Dr. P.D. Sethi Annual Award for Best Paper in Pharmaceutical Analysis” 2012
6.      Certificate of Merit - “Dr. P.D. Sethi Annual Award for Best Paper in Pharmaceutical Analysis” 2012
7.      Certificate of Merit - “Dr. P.D. Sethi Annual Award for Best Paper in Pharmaceutical Analysis” 2012
8.      1st Prizein3rd CDRI-NIPER (RBL) Symposium on Medicinal Chemistry and Pharmaceutical Sciences, CDRI, Luknow, March, 2011
9.      Certificate of Merit - “Dr. P.D. Sethi Annual Award for Best Paper in Pharmaceutical Analysis” 2010
10.   1st Prize in 14th National Convention of Society of Pharmacognosy, Hindu College of Pharmacy, Sonipat, Haryana, February 2010
11.   3rd Prize in 14th National Convention of Society of Pharmacognosy, Hindu College of Pharmacy, Sonipat, Haryana, February 2010
12.   “Dr. P.D. Sethi Research Paper Annual Award on Application of LC/HPTLC in Pharma, Herbal and Miscellaneous Analysis” 2009
13.   2nd Prize in Gujarat State Pharmacy Paper Presentation-conducted by GUJCOST, Shri Sarvajanik Pharmacy College Mehsana, Gandhinagar, January 2009
14.   2nd Prize in Gujarat State Pharmacy Paper Presentation-conducted by GUJCOST, Shri Sarvajanik Pharmacy College Mehsana, Gandhinagar, January 2009
15.   GovindAchari Prize. 40th Annual Conference of Indian Pharmacological Society, NIPER-SAS Nagar, November 2007
16.   1st Prize in UGC-DSA Symposium on “Recent Advances in Reproduction, Endocrinology & Development and Associated Disorders”, The M.S. University of Baroda, Vadodara, January 2006
17.   3rd Prize in National Symposium on Contemporary Developments in Life Sciences, Hemchandracharya North Gujarat University, Patan, March 2006
18.   Indian Drugs Best Paper Award (2002):For the best paper in the discipline of Pharmacology

D. Patents

Sr. No. Title
      “Minicircle DNA vector for inducing pluripotency in nucleated blood cells and other cell types” Indian patent Application No.: 1971/MUM/2014
“Novel pyrazolopyrimidinones or pharmaceutical acceptable salts and process for the preparation of these compounds thereof” Indian Patent Application No.: 1918/MUM/2013
“Oral gastro retentive fixed dose pharmaceutical compositions for the treatment of tuberculosis and process for preparation thereof” Indian Patent Application No.: 2829/MUM/2009